Abstract

Tumor tissues consist of heterogeneous cells that originate from stem cells; however, their cell fate determination program remains incompletely understood. Using patient-derived organoids established from patients with advanced colorectal cancer (CRC), we evaluated the potential of olfactomedin 4 (OLFM4)+ stem cells to produce a bifurcated lineage of progenies with absorptive and secretory properties. In the early phases of organoid reconstruction, OLFM4+ cells preferentially gave rise to secretory cells. Additionally, we found that Paneth-like cells, which do not exist in the normal colon, were induced in response to Notch signaling inhibition. Video recordings of single OLFM4+ cells revealed that organoids containing Paneth-like cells were effectively propagated and that their selective ablation led to organoid collapse. In tumor tissues, Paneth-like cells were identified only in the region where tumor cells lost cell adhesion. These findings indicate that Paneth-like cells are directly produced by OLFM4+ stem cells and that their interaction contributes to tumor formation by providing niche factors. This study reveals the importance of the cell fate specification program for building a complete tumor cellular ecosystem, which might be targeted with novel therapeutics.

An analysis of the reconstitution process of orgenoids revelaed that OLFM4+ cells in colorectal cancer directrly generate Paneth-like cells, which supported OLFM4+ cells growth by providing niche.

Details

Title
Paneth-like cells produced from OLFM4+ stem cells support OLFM4+ stem cell growth in advanced colorectal cancer
Author
Sakahara, Mizuho 1 ; Okamoto, Takuya 2 ; Srivastava, Upasna 3 ; Natsume, Yasuko 1 ; Yamanaka, Hitomi 1 ; Suzuki, Yutaka 4   VIAFID ORCID Logo  ; Obama, Kazutaka 5 ; Nagayama, Satoshi 6   VIAFID ORCID Logo  ; Yao, Ryoji 1   VIAFID ORCID Logo 

 Cancer Institute, Japanese Foundation for Cancer Research, Department of Cell Biology, Tokyo, Japan (GRID:grid.410807.a) (ISNI:0000 0001 0037 4131) 
 Cancer Institute, Japanese Foundation for Cancer Research, Department of Cell Biology, Tokyo, Japan (GRID:grid.410807.a) (ISNI:0000 0001 0037 4131); Kyoto University, Department of Surgery, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
 Cancer Institute, Japanese Foundation for Cancer Research, Department of Cell Biology, Tokyo, Japan (GRID:grid.410807.a) (ISNI:0000 0001 0037 4131); Yale School of Medicine, Child Study Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 The University of Tokyo, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, Kashiwa, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Kyoto University, Department of Surgery, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
 Cancer Institute, Japanese Foundation for Cancer Research, Department of Cell Biology, Tokyo, Japan (GRID:grid.410807.a) (ISNI:0000 0001 0037 4131); Kyoto University, Department of Surgery, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); Uji-Tokushukai Medical Center, Department of Surgery, Kyoto, Japan (GRID:grid.258799.8) 
Pages
27
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2910735346
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.